SILVESTRO, MARCELLO
 Distribuzione geografica
Continente #
EU - Europa 1.732
AS - Asia 1.056
NA - Nord America 642
SA - Sud America 178
AF - Africa 9
OC - Oceania 3
Totale 3.620
Nazione #
RU - Federazione Russa 989
US - Stati Uniti d'America 617
SG - Singapore 453
IT - Italia 251
CN - Cina 235
IE - Irlanda 206
BR - Brasile 147
HK - Hong Kong 141
DE - Germania 85
GB - Regno Unito 57
KR - Corea 56
VN - Vietnam 52
JP - Giappone 48
IN - India 28
FI - Finlandia 26
CA - Canada 19
AT - Austria 18
SE - Svezia 17
GR - Grecia 16
AR - Argentina 14
CZ - Repubblica Ceca 14
UA - Ucraina 11
BE - Belgio 10
BD - Bangladesh 8
ES - Italia 8
FR - Francia 6
NL - Olanda 6
CO - Colombia 4
EC - Ecuador 4
ID - Indonesia 4
IQ - Iraq 4
IR - Iran 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
MX - Messico 3
PY - Paraguay 3
TR - Turchia 3
ZA - Sudafrica 3
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
KE - Kenya 2
LV - Lettonia 2
MT - Malta 2
PK - Pakistan 2
PL - Polonia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
GE - Georgia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.620
Città #
Moscow 366
Dublin 206
Singapore 192
Hong Kong 141
Santa Clara 132
Naples 66
Chandler 56
Seoul 56
Ashburn 45
Hefei 41
Beijing 38
Munich 38
Jacksonville 26
Roxbury 26
Princeton 25
Bremen 24
Dallas 20
Bengaluru 19
The Dalles 19
Medford 18
New York 17
Ho Chi Minh City 15
Brno 13
Helsinki 13
São Paulo 13
Aversa 11
Hanoi 11
Los Angeles 11
Turku 10
Vienna 10
Caserta 9
Des Moines 9
Reggio Emilia 9
Cambridge 8
Milan 8
Viterbo 8
Belo Horizonte 7
Boardman 7
Hasselt 7
Nanjing 7
Napoli 7
Nuremberg 7
Atlanta 5
Bologna 5
Brooklyn 5
Falkenstein 5
Hebei 5
London 5
Montreal 5
Norwalk 5
San Francisco 5
Stockholm 5
Wilmington 5
Amsterdam 4
Avella 4
Curitiba 4
Dhaka 4
Guangzhou 4
Guarulhos 4
Sacramento 4
Salerno 4
Shenyang 4
Tashkent 4
Tokyo 4
Ann Arbor 3
Brussels 3
Florence 3
Phoenix 3
Porto Alegre 3
Rio de Janeiro 3
São Leopoldo 3
Toronto 3
Villaricca 3
Adrogué 2
Afragola 2
Alexandria 2
Belpasso 2
Biên Hòa 2
Boston 2
Brasília 2
Campinas 2
Canoas 2
Caruaru 2
Castellammare di Stabia 2
Catania 2
Cerquilho 2
Chennai 2
Chicago 2
Columbus 2
Formosa 2
Frankfurt am Main 2
Giugliano in Campania 2
Hangzhou 2
Houston 2
Indore 2
Jinan 2
L'aquila 2
Lappeenranta 2
Las Vegas 2
Leganés 2
Totale 1.951
Nome #
Cluster headache pathophysiology: What we have learned from advanced neuroimaging 118
A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG 112
Telemedicine application to headache: a critical review 105
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 96
Cognitive, behavioral, and brain functional connectivity correlates of fatigue in amyotrophic lateral sclerosis 94
Can Craniometry Play a Role in Cluster Headache Diagnosis? A Pilot Exploratory TC-3D Based Study 94
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 92
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 91
Advances in migraine neuroimaging and clinical utility: from the MRI to the bedside 90
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 86
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 86
Infodemiology of cluster headache seasonality: A proof of concept by a Google Trends analysis 85
Resting state fMRI analysis of pseudobulbar affect in Amyotrophic Lateral Sclerosis (ALS): motor dysfunction of emotional expression 80
Disconnectome of the migraine brain: a "connectopathy" model 79
The "Cluster-SUNCT Syndrome": The Lumper-Splitter Problem 78
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience 78
Coping Strategies in Migraine without Aura: A Cross-Sectional Study 77
The conundrum of relationship between pain and visual pathway in migraine with aura 75
Effectiveness and safety of CGRP monoclonal antibodies in migraine related to mitochondrial diseases in patients with NARP and PEO syndromes 74
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 73
Readability Analysis of Online Headache and Migraine Information 73
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 72
Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials 63
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 63
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 61
Reduced neurovascular coupling of the visual network in migraine patients with aura as revealed with arterial spin labeling MRI: is there a demand-supply mismatch behind the scenes? 61
Functional neuroimaging biomarkers in migraine: diagnostic, prognostic and therapeutic implications 61
Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment 61
Erenumab Efficacy on Comorbid Cluster Headache in Patients With Migraine: A Real-World Case Series 60
Psychological Support for Family Caregivers of Patients With Amyotrophic Lateral Sclerosis at the Time of the Coronavirus Disease 2019 Pandemic: A Pilot Study Using a Telemedicine Approach 60
Headache Worsening after COVID-19 Vaccination: An Online Questionnaire-Based Study on 841 Patients with Migraine 59
The "Ram's Horns Sign": A Case Report of an Unusual Side Effect of OnabotulinumtoxinA in a Chronic Migraine Patient 59
SUNCT-Induced Jaw Opening: A Rare Trigeminal Autonomic Phenotype 59
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 58
Migraine in the Time of COVID-19 55
Migraine as a Cortical Brain Disorder 55
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience 54
Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults 54
Pain Perception and Migraine 52
Screening of visuospatial abilities in amyotrophic lateral sclerosis (ALS): a pilot study using the battery for visuospatial abilities (BVA) 51
Recent Insights in Migraine With Aura: A Narrative Review of Advanced Neuroimaging 51
Functional connectivity changes in complex migraine aura: beyond the visual network 51
Shedding light on migraine with aura: the clarifying role of advanced neuroimaging investigations 47
Perceived ease-of-usability and local tolerability using CGRP monoclonal antibody autoinjectors vs. syringes: an online questionnaire-based study in patients with migraine 47
Migraine Treatment: Towards New Pharmacological Targets 30
A case of rapidly progressive juvenile amyotrophic lateral sclerosis associated with a pathogenetic heterozygous de novo variant in the FUS gene 28
Evidence-based guidelines for the pharmacological treatment of migraine, summary version 25
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 24
"Forced Normalization": Could It Occur Also in Migraine Patients? 23
Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine 22
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study 22
A 67-Year-Old Woman With Recurrent Headache, Migratory Focal Symptoms, and Impaired Consciousness 22
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 22
The relevance of cortical thickness in migraine sufferers and implications to therapy 21
Evidence-based guidelines for the pharmacological treatment of migraine 21
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors 21
No additional benefit with detoxification strategies: A real world experience in 200 patients with chronic migraine and either simple or complex MOH treated with CGRP monoclonal antibodies 21
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients 20
Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication—a real-world study 18
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 18
Prospective memory is dysfunctional in migraine without aura 18
Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review 18
Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence 18
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study 18
Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients 16
Refractory migraine profile in CGRP-monoclonal antibodies scenario 16
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 15
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men 13
Migraine Does Not Affect Pain Intensity Perception: A Cross-Sectional Study 13
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 13
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 12
Pain-Related Brain Connectivity Changes in Migraine: A Narrative Review and Proof of Concept about Possible Novel Treatments Interference 12
Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study 11
Idiopathic hypertrophic pachymeningitis mimicking hemicrania continua: An unusual clinical case 9
Physiopathology of Migraine: What Have We Learned from Functional Imaging? 8
Totale 3.718
Categoria #
all - tutte 14.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.534


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 1 13 7 1 5 13 3
2021/2022210 11 5 9 12 65 8 3 5 6 9 22 55
2022/2023339 40 12 6 18 43 13 0 15 174 2 13 3
2023/2024237 11 19 11 13 60 28 10 10 6 4 16 49
2024/2025817 1 20 12 21 154 76 104 63 140 83 91 52
2025/20261.957 167 211 182 174 534 689 0 0 0 0 0 0
Totale 3.718